Viemed Healthcare Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Viemed Healthcare wird ein Gewinn- und Umsatzwachstum von 49.4% bzw. 17.8% pro Jahr prognostiziert, während der Gewinn pro Aktie um 50.1% pro Jahr wachsen soll.

Wichtige Informationen

49.4%

Wachstumsrate der Gewinne

50.1%

EPS-Wachstumsrate

Healthcare Gewinnwachstum63.8%
Wachstumsrate der Einnahmen17.8%
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

Low

Zuletzt aktualisiert06 Dec 2023

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Is Viemed Healthcare (TSE:VMD) A Risky Investment?

Sep 13
Is Viemed Healthcare (TSE:VMD) A Risky Investment?

The Returns On Capital At Viemed Healthcare (TSE:VMD) Don't Inspire Confidence

May 27
The Returns On Capital At Viemed Healthcare (TSE:VMD) Don't Inspire Confidence

Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?

Feb 18
Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?

Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?

Oct 27
Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?

Some Investors May Be Worried About Viemed Healthcare's (TSE:VMD) Returns On Capital

Jul 08
Some Investors May Be Worried About Viemed Healthcare's (TSE:VMD) Returns On Capital

Does This Valuation Of Viemed Healthcare, Inc. (TSE:VMD) Imply Investors Are Overpaying?

Mar 10
Does This Valuation Of Viemed Healthcare, Inc. (TSE:VMD) Imply Investors Are Overpaying?

These 4 Measures Indicate That Viemed Healthcare (TSE:VMD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Viemed Healthcare (TSE:VMD) Is Using Debt Reasonably Well

Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why

Jun 04
Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why

Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt

May 18
Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt

Viemed Healthcare, Inc.'s (TSE:VMD) Stock Is Going Strong: Is the Market Following Fundamentals?

Mar 03
Viemed Healthcare, Inc.'s (TSE:VMD) Stock Is Going Strong: Is the Market Following Fundamentals?

I Ran A Stock Scan For Earnings Growth And Viemed Healthcare (TSE:VMD) Passed With Ease

Feb 16
I Ran A Stock Scan For Earnings Growth And Viemed Healthcare (TSE:VMD) Passed With Ease

Viemed Healthcare (TSE:VMD) Seems To Use Debt Rather Sparingly

Feb 03
Viemed Healthcare (TSE:VMD) Seems To Use Debt Rather Sparingly

If You Had Bought Viemed Healthcare (TSE:VMD) Shares Three Years Ago You'd Have Earned 319% Returns

Jan 21
If You Had Bought Viemed Healthcare (TSE:VMD) Shares Three Years Ago You'd Have Earned 319% Returns

Did Viemed Healthcare, Inc. (TSE:VMD) Insiders Sell Shares?

Jan 08
Did Viemed Healthcare, Inc. (TSE:VMD) Insiders Sell Shares?

Should You Rely On Viemed Healthcare's (TSE:VMD) Earnings Growth?

Dec 22
Should You Rely On Viemed Healthcare's (TSE:VMD) Earnings Growth?

Declining Stock and Solid Fundamentals: Is The Market Wrong About Viemed Healthcare, Inc. (TSE:VMD)?

Nov 25
Declining Stock and Solid Fundamentals: Is The Market Wrong About Viemed Healthcare, Inc. (TSE:VMD)?

Gewinn- und Umsatzwachstumsprognosen

TSX:VMD - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2025249N/A20N/A1
12/31/20242221718N/A3
12/31/20231831117N/A3
9/30/202317091640N/A
6/30/202315671134N/A
3/31/20231466731N/A
12/31/20221396528N/A
9/30/20221338529N/A
6/30/20221279026N/A
3/31/20221219325N/A
12/31/20211179322N/A
9/30/202111610220N/A
6/30/2021120111022N/A
3/31/2021136292939N/A
12/31/2020131322235N/A
9/30/2020122292637N/A
6/30/2020108292435N/A
3/31/20208611219N/A
12/31/2019809619N/A
9/30/2019769720N/A
6/30/2019738819N/A
3/31/20196891622N/A
12/31/201864101622N/A
9/30/20186071115N/A
6/30/20185691013N/A
3/31/201851869N/A
12/31/2017478812N/A
9/30/201743111214N/A
12/31/2016311N/A6N/A
12/31/20153810N/A10N/A
12/31/2014239N/A8N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: VMDDas prognostizierte Gewinnwachstum (49.4% pro Jahr) liegt über der Sparquote (1.9%).

Ertrag vs. Markt: VMDDie Erträge des Unternehmens (49.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (16% pro Jahr).

Hohe Wachstumserträge: VMDEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: VMDDie Einnahmen des Unternehmens (17.8% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Canadian (6.8% pro Jahr).

Hohe Wachstumseinnahmen: VMDDie Einnahmen des Unternehmens (17.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von VMD in 3 Jahren voraussichtlich hoch sein wird


Wachstumsunternehmen entdecken